NO20006575D0 - Fremgangsmåte for å redusere skadelige effekter av stråleterapi på hud og slimhinner hos dyr - Google Patents

Fremgangsmåte for å redusere skadelige effekter av stråleterapi på hud og slimhinner hos dyr

Info

Publication number
NO20006575D0
NO20006575D0 NO20006575A NO20006575A NO20006575D0 NO 20006575 D0 NO20006575 D0 NO 20006575D0 NO 20006575 A NO20006575 A NO 20006575A NO 20006575 A NO20006575 A NO 20006575A NO 20006575 D0 NO20006575 D0 NO 20006575D0
Authority
NO
Norway
Prior art keywords
animals
skin
procedure
radiation therapy
mucous membranes
Prior art date
Application number
NO20006575A
Other languages
English (en)
Other versions
NO329910B1 (no
NO20006575L (no
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Univ Colorado State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co, Univ Colorado State Res Found filed Critical Colgate Palmolive Co
Publication of NO20006575D0 publication Critical patent/NO20006575D0/no
Publication of NO20006575L publication Critical patent/NO20006575L/no
Publication of NO329910B1 publication Critical patent/NO329910B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20006575A 1998-06-29 2000-12-21 Sammensetning for a lindre skadelige effekter av straleterapi pa hud og slimhinner hos kjaeledyr NO329910B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (en) 1998-06-29 1999-06-24 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (3)

Publication Number Publication Date
NO20006575D0 true NO20006575D0 (no) 2000-12-21
NO20006575L NO20006575L (no) 2001-02-28
NO329910B1 NO329910B1 (no) 2011-01-24

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006575A NO329910B1 (no) 1998-06-29 2000-12-21 Sammensetning for a lindre skadelige effekter av straleterapi pa hud og slimhinner hos kjaeledyr

Country Status (17)

Country Link
US (1) US6015798A (no)
EP (1) EP1091734B1 (no)
JP (2) JP4860814B2 (no)
AR (1) AR019728A1 (no)
AT (1) ATE249821T1 (no)
AU (1) AU761266B2 (no)
BR (1) BR9911663A (no)
CA (1) CA2336628C (no)
DE (1) DE69911409T2 (no)
DK (1) DK1091734T3 (no)
ES (1) ES2207951T3 (no)
MX (1) MXPA01000152A (no)
NO (1) NO329910B1 (no)
NZ (1) NZ508766A (no)
TR (1) TR200100457T2 (no)
WO (1) WO2000000189A1 (no)
ZA (1) ZA200007650B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
MXPA02002195A (es) * 1999-09-09 2002-09-18 Nestle Sa Mejoramiento del estado de mascotas viejas.
BR0110534A (pt) * 2000-05-01 2003-04-01 Iams Company Composição alimentìcia para animais de estimação para a redução de respostas inflamatórias em gatos; e método para a redução de respostas inflamatórias em gatos
AU6527301A (en) 2000-06-01 2001-12-11 United Feeds Inc Animal food and method
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
DK1656130T3 (da) * 2003-08-11 2008-11-24 Hills Pet Nutrition Inc Omega-3-fedtsyrer til behandling af osteoarthritis hos hunde
FI20060154A7 (fi) 2003-08-18 2006-05-11 Btg Int Ltd Neurogeneratiivisten tilojen hoito
US7744917B2 (en) * 2003-11-25 2010-06-29 Virginia Intellectual Properties Inc. Composition for animal consumption and method for reducing MAP kinase activity
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
WO2006072084A2 (en) 2004-12-30 2006-07-06 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a growing animal
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
CA2702577A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
EP2224911A4 (en) * 2007-11-30 2013-05-08 Jbs United Inc METHOD AND COMPOSITION FOR TREATING LUNG HAEMORRHAGIA
RU2607604C2 (ru) * 2012-11-15 2017-01-10 Хилл'С Пет Ньютришн, Инк. Профилактика образования безоаров путем ограничения содержания минеральных веществ в рационе
US11065220B2 (en) 2017-02-13 2021-07-20 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
AU2019355862B2 (en) 2018-10-01 2021-04-22 Wintermute Biomedical, Inc. Therapeutic compositions
AU2019478729B2 (en) * 2019-12-19 2024-08-29 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions
EP4017276A1 (en) 2019-12-19 2022-06-29 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety
EP4199738A1 (en) * 2020-10-21 2023-06-28 Hill's Pet Nutrition, Inc. Pet food compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2052066T3 (es) * 1988-10-31 1994-07-01 Sandoz Nutrition Ltd Mejoras en o relacionadas con compuestos organicos.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma

Also Published As

Publication number Publication date
MXPA01000152A (es) 2002-10-17
WO2000000189A1 (en) 2000-01-06
EP1091734B1 (en) 2003-09-17
BR9911663A (pt) 2005-12-20
JP2002519320A (ja) 2002-07-02
EP1091734A1 (en) 2001-04-18
CA2336628C (en) 2009-03-24
NO329910B1 (no) 2011-01-24
ZA200007650B (en) 2002-08-28
ATE249821T1 (de) 2003-10-15
JP4860814B2 (ja) 2012-01-25
AR019728A1 (es) 2002-03-13
TR200100457T2 (tr) 2001-08-21
DE69911409T2 (de) 2004-07-08
NO20006575L (no) 2001-02-28
CA2336628A1 (en) 2000-01-06
JP5704791B2 (ja) 2015-04-22
DK1091734T3 (da) 2004-01-26
AU4716799A (en) 2000-01-17
ES2207951T3 (es) 2004-06-01
NZ508766A (en) 2003-05-30
JP2009035533A (ja) 2009-02-19
AU761266B2 (en) 2003-05-29
US6015798A (en) 2000-01-18
DE69911409D1 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
NO20006575L (no) Fremgangsmåte for å redusere skadelige effekter av stråleterapi på hud og slimhinner hos dyr
DE69825447D1 (de) Gerät zur dermatologischen behandlung
DE69622993D1 (de) Sanft behandeltes ungekrepptes durchblasgetrocknetes tissue
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
DE69522448D1 (de) Gewebebehandlungskassette
PT948308E (pt) Metodos para o tratamento de pigmentacao da pele
NO984431D0 (no) FremgangsmÕte for behandling av smerte
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO980687L (no) System og fremgangsmåte for perfusjon-hypertermibehandling
BR9707008A (pt) Tratamento do cabelo ou da pele
NO20000996D0 (no) Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO983641D0 (no) Fremgangsmåte til behandling og farmasöytisk preparat
FI951060A7 (fi) Formulaatioita ja hoitomenetelmiä
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69732024D1 (de) Haarbehandlungsmittel
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
NO984446D0 (no) FremgangsmÕte for behandling av smerte
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
FI971584L (fi) Estävä ja hoitava aine tyypin I allergiatauteja varten
BR9706943A (pt) Formulação de tratamento de pele e seus usos
DE59708501D1 (de) Haarbehandlungsmittel
AU7903898A (en) Assessment of human skin damage following exposure to harmful agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees